Menu

Modified Pigs as Organ Donors?

Researchers have edited more than 60 genes in pig embryos to facilitate organ donations for humans.

Oct 9, 2015
Karen Zusi

FLICKR, NICK SALTMARSHA team of researchers has taken a step toward modifying pigs to become viable alternatives to human organ donors, George Church from Harvard University announced at a US National Academy of Sciences meeting earlier this week (October 5), according to Nature.

Doctors have been slow to use pigs as organ-donor alternatives for at least two reasons: first, the pig genome has a number of endogenous retroviruses that are harmless to pigs, but that could infect humans; second, the human immune system will target pig-specific proteins in the cell membranes, trying to reject the foreign bodies.

Church and his colleagues used CRISPR/Cas9 to inactivate 62 of the pig’s endogenous retroviruses in embryos. In a separate set of pig embryos, the team modified genes coding for the cell membrane proteins that would trigger a human immune response. Pigs intended as organ donors in the future will require both sets of gene edits, which amount to ten times more than previous edits in other animals.

CRISPR pioneer Jennifer Doudna, a biochemist at University of California, Berkeley, told Nature she was impressed by the number of edited genes.

Because the work is unpublished, Church and his colleagues didn’t reveal the exact genes that they targeted. But, according to Nature, Church said that both sets of edited pig embryos are almost ready to implant into mother pigs. “This is something I’ve been wanting to do for almost a decade,” he told Nature.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!